Other less common strategies are usually reserved for third line
strategy and can include the initiation of a tricyclic antidepressant
(TCA), a monoamine oxidase inhibitor (MAOI), or the use of other
adjunct pharmacotherapies (Trivedi et al., 2008; Philip et al.,
2010).